Region

Documents

Beta-Glucuronidase Removal from Hydrolyzed Pain Management Urine Samples (TN-0083)


Abstract:
The escalating abuse of pain medicines has mandated that health care providers and practitioners routinely perform urine drug testing. Most laboratories opt for a dilute-and-shoot approach, along with enzymatic hydrolysis that requires no sample cleanup. The addition of extra protein as a result of hydrolysis using ß-glucuronidase to the urine can result in fouling of the LC column and loss of productivity. In this work, we present an automated method that uses an Impact™ Protein Precipitation 96-well plate to remove a majority of the proteins from hydrolyzed urine.
Document Type:
Technical Notes
Industries:
Forensics/Toxicology Clinical
Techniques:
Sample Prep HPLC / UHPLC
Brands:
Impact Kinetex
PDF Link:
Click here